Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Amodiaquine hydrochloride

SKU: orb1224375

Description

A 4-aminoquinoline compound with anti-inflammatory properties. (In Vitro):Amodiaquine (10-20 μM; 4 hours) treatment suppresses LPS-induced expression of proinflammatory cytokines (IL-1β, interleukin-6, TNF-α and iNOS) in a dose-dependent manner.Amodiaquine (5 μM; 24 hours) significantly inhibits neurotoxin (6-OHDA-induced cell death in primary dopamine cells as examined by the number of TH+ neurons and dopamine uptake. The neuroprotective effect of Amodiaquine is also observed in rat PC12 cells.(In Vivo):Amodiaquine (40 mg/kg; intraperitoneal injection; daily; for 3 days; male ICR mice) treatment diminishes perihematomal activation of microglia/macrophages and astrocytes. Amodiaquine also suppresses ICH-induced mRNA expression of IL-1β, CCL2 and CXCL2, and ameliorated motor dysfunction of mice.

Research Area

Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number6398-98-7
MW464.82
Purity>98% (HPLC)
FormulaC20H28Cl3N3O3
SMILESO.O.Cl.Cl.CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1
TargetHistamine Receptor
SolubilityWater: 10 mM

Bioactivity

In Vivo
Amodiaquine (40 mg/kg; intraperitoneal injection; daily; for 3 days; male ICR mice) treatment diminishes perihematomal activation of microglia/macrophages and astrocytes. Amodiaquine also suppresses ICH-induced mRNA expression of IL-1β, CCL2 and CXCL2, and ameliorated motor dysfunction of mice. Animal model: Male ICR mice (8-10 weeks of age) induced ntracerebral hemorrhage (ICH). Dosage: 40 mg/kg. Administration: Intraperitoneal injection; daily; for 3 days. Result: Diminished perihematomal activation of microglia/macrophages and astrocytes.
In Vitro
Amodiaquine (10-20 μM; 4 hours) treatment suppresses LPS-induced expression of proinflammatory cytokines (IL-1β, interleukin-6, TNF-α and iNOS) in a dose-dependent manner. Amodiaquine (5 μM; 24 hours) significantly inhibits neurotoxin (6-OHDA-induced cell death in primary dopamine cells as examined by the number of TH+ neurons and dopamine uptake. The neuroprotective effect of Amodiaquine is also observed in rat PC12 cells. RT-PCR Cell line: Primary microglia. Concentration: 10 μM, 15 μM, 20 μM. Incubation time: 4 hours. Result: Suppressed LPS-induced expression of proinflammatory cytokines (IL-1β, interleukin-6, TNF-α and iNOS) in a dose-dependent manner.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • Amodiaquine hydrochloride [orb1909163]

    69-44-3

    428.78

    C20H24Cl3N3O

    100 mg
  • Amodiaquine impurity 2 [orb3217229]

    1246819-11-3

    364.27

    C18H19Cl2N3O

    10 mg, 50 mg
  • Amodiaquine dihydrochloride dihydrate [orb1310667]

    99.97% (May vary between batches)

    6398-98-7

    464.82

    C20H28Cl3N3O3

    1 ml x 10 mM (in DMSO), 500 mg, 100 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Protocol Information

Available Sizes

Select a size below

500 mg
50 mg
$ 80.00
100 mg
$ 100.00
200 mg
$ 140.00